Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pivotal pharmacokinetic trial of a hormone therapy, TX 12001HR, for the treatment of menopausal syndrome.

Next Previous
X
Search
Trial Profile

Pivotal pharmacokinetic trial of a hormone therapy, TX 12001HR, for the treatment of menopausal syndrome.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 09 Jan 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estradiol/progesterone (Primary) ; Estradiol; Progesterone
  • Indications Menopausal syndrome
  • Focus Pharmacokinetics; Registrational
  • Sponsors TherapeuticsMD

    • Most Recent Events

    • 12 Oct 2013 Primary endpoint 'Peak-drug-concentration' has been met according to results presented at the 24th Annual Meeting of the North American Menopause Society.
    • 12 Oct 2013 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met according to results presented at the 24th Annual Meeting of the North American Menopause Society.
    • 09 Oct 2013 Results have been presented at The North American Menopause Society 2013 Annual Meeting according to a TherapeuticsMD media release. Results were also summarised in the media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top